Rapid-Acting Insulin Administration Protocol
For an adult without renal or hepatic impairment, administer rapid-acting insulin (lispro, aspart, or glulisine) immediately before meals (0-15 minutes prior) as part of a basal-bolus regimen, with prandial doses divided equally across three meals and supplemented with correction doses based on blood glucose levels.
Dosing Protocol
Initial Dose Calculation
Calculate total daily insulin dose based on blood glucose levels 1:
- 0.4 U/kg/day for blood glucose 140-200 mg/dL (7.8-11.1 mmol/L)
- 0.5 U/kg/day for blood glucose 201-400 mg/dL (11.2-22.2 mmol/L)
Distribute as 50% basal insulin and 50% nutritional (prandial) insulin 1.
Prandial Insulin Administration
- Divide the prandial portion equally into three doses before each meal 1
- Administer immediately before meals (within 0-15 minutes) 1, 2, 3
- Hold prandial insulin if patient cannot eat 1
The most recent ADA guidelines 4, 5 recommend starting with 4 units per meal or 10% of basal dose when adding prandial insulin, then titrating by 1-2 units or 10-15% twice weekly based on postprandial glucose.
Timing Considerations
Critical nuance: While rapid-acting insulins can be given immediately before meals, research shows that in hyperglycemic patients (glucose >180 mg/dL), administering lispro 15 minutes before the meal significantly improves postprandial glucose control 6. However, giving it 30 minutes early risks late hypoglycemia. The practical recommendation remains 0-15 minutes before meals for safety and flexibility 7, 8.
Correction (Supplemental) Doses
Add correction insulin to scheduled prandial doses based on blood glucose 1:
| Blood Glucose (mg/dL) | Insulin-Sensitive | Usual | Insulin-Resistant |
|---|---|---|---|
| 141-180 | 2 units | 4 units | 6 units |
| 181-220 | 4 units | 6 units | 8 units |
| 221-260 | 6 units | 8 units | 10 units |
| 261-300 | 8 units | 10 units | 12 units |
| 301-350 | 10 units | 12 units | 14 units |
| 351-400 | 12 units | 14 units | 16 units |
| ≥400 | 14 units | 16 units | 18 units |
Start with "usual" column for most patients. Use insulin-sensitive column for elderly or those not eating. Use insulin-resistant column for patients on corticosteroids or previously requiring >80 units/day 1.
Give half the correction dose at bedtime 1.
NPO (Non-Eating) Patients
For patients unable to eat:
- Continue basal insulin
- Give rapid-acting insulin every 4-6 hours for correction only (not scheduled prandial doses) 1
- Use the insulin-sensitive correction scale 1
Pharmacokinetic Properties
All three rapid-acting insulins (lispro, aspart, glulisine) have similar profiles 9, 10:
- Onset: 10-15 minutes
- Peak: 40-50 minutes (vs. 80-120 minutes for regular insulin)
- Duration: ~4 hours
- Half-life: ~81 minutes for aspart 9
These insulins are absorbed to a similar extent and have comparable efficacy for A1C reduction and postprandial glucose control 10, 11, 12.
Mixing Guidelines
Rapid-acting insulins can be mixed with NPH if needed 2, 3:
- Mix and inject within 15 minutes before meals
- The rapid-acting component maintains its quick onset when mixed with NPH
- Never mix with insulin glargine (incompatible pH) 2, 3
Common Pitfalls
Avoid sliding-scale insulin as sole therapy - it increases hyperglycemia risk 3-fold 1. Always use scheduled basal-bolus regimen.
Don't give prandial insulin if patient cannot eat - this is a major cause of hypoglycemia 1.
Adjust for hypoglycemia - if hypoglycemia occurs without clear cause, reduce the corresponding insulin dose by 10-20% 1, 4, 5.
Monitor for overbasalization - if basal dose exceeds ~0.5 U/kg/day or postprandial glucose remains elevated despite adequate basal control, consider adding or adjusting prandial insulin rather than increasing basal further 4, 5.
Injection Technique
- Subcutaneous injection into abdomen (fastest absorption), arms, thighs, or buttocks 2
- Rotate within one area rather than between different areas to reduce absorption variability 2
- Inject at 90° angle for most adults; thin individuals may need 45° angle 2
- Keep needle in skin for 5 seconds after injection, especially with pens 2